Janssen-Cilag: putting patients at the heart of everything we do Janssen-Cilag: putting patients at the heart of everything we do

Vermox®

> More about Vermox®
About Vermox®

FAQs



A patient information leaflet is included in every pack of medicine. You should read this carefully before taking your medicine.

The patient information leaflets for Vermox® can be found here.

If you have any questions about a condition or medicine, always consult a healthcare professional.

Vermox® is available as an orange coloured and flavoured tablet containing the active ingredient mebendazole. Vermox® is also available as a white, banana flavoured suspension, containing the active ingredient mebendazole.

Vermox® belongs to a group of medicines called anthelmintics.

Vermox® is used for the treatment of threadworms and other common worm infections (e.g. whipworm, pinworm, roundworm and hookworm).

Vermox® works by preventing the worms from obtaining glucose so that they are unable to maintain enough energy to survive.

Vermox® will kill threadworms after a single dose. Your doctor may recommend that a second dose is taken after 2 weeks in case of re-infection.

For other common worm infections, Vermox® should be taken for three consecutive days or as directed by your doctor.

Vermox® is generally well tolerated. However, patients with high parasitic burdens when treated with Vermox® have manifested diarrhoea and abdominal pain. Rarely, allergic reactions have been reported.

For further information about Vermox®, including possible side effects, please refer to the patient information leaflet or speak to your doctor.


Patient Information Leaflets:

- Vermox® 100mg / 5ml Oral Suspension
- Vermox® 100mg Tablets

Item code: NPR/10-0010
Date of Preparation: May 2010